dactinomycin has been researched along with Biliary Tract Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhashem, F; Deniz, K; Karakukcu, M; Ozdemir, MA; Patiroglu, T; Unal, E; Yikilmaz, A; Yilmaz, E | 1 |
| Anderson, JR; Breneman, JC; Cripe, TP; Hawkins, DS; Hayes-Jordan, A; Meyer, WH; Meza, JL; Pappo, AS; Parham, DM; Walterhouse, DO | 1 |
| Berghoff, R; Cédola, J; Drut, R; Pollono, DG; Tomarchio, S; Urrutia, A | 1 |
3 other study(ies) available for dactinomycin and Biliary Tract Cancer
| Article | Year |
|---|---|
Biliary Rhabdomyosarcoma in an Infant Male With Neurofibromatosis Type 1.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Chemoradiotherapy; Child; Cyclophosphamide; Dactinomycin; Humans; Male; Neurofibromatosis 1; Rhabdomyosarcoma; Vincristine | 2019 |
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Rhabdomyosarcoma, Embryonal; Vaginal Neoplasms; Vincristine; Young Adult | 2017 |
Rhabdomyosarcoma of extrahepatic biliary tree: initial treatment with chemotherapy and conservative surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Rhabdomyosarcoma; Vincristine | 1998 |